These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2965784)

  • 21. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 1996 Feb; 178(2):176-81. PubMed ID: 8683386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
    Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B
    Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dapagliflozin exerts positive effects on beta cells, decreases glucagon and does not alter beta- to alpha-cell transdifferentiation in mouse models of diabetes and insulin resistance.
    Tanday N; Irwin N; Flatt PR; Moffett RC
    Biochem Pharmacol; 2020 Jul; 177():114009. PubMed ID: 32360307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
    Reddy S; Chang M; Robinson E
    Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes.
    Cam MC; Rodrigues B; McNeill JH
    Eur J Endocrinol; 1999 Nov; 141(5):546-54. PubMed ID: 10576774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exendin-4 exerts its effects through the NGF/p75NTR system in diabetic mouse pancreas.
    Gezginci-Oktayoglu S; Bolkent S
    Biochem Cell Biol; 2009 Aug; 87(4):641-51. PubMed ID: 19767827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very-low-dose streptozotocin induces diabetes in insulin promoter-mB7-1 transgenic mice.
    Harlan DM; Barnett MA; Abe R; Pechhold K; Patterson NB; Gray GS; June CH
    Diabetes; 1995 Jul; 44(7):816-23. PubMed ID: 7540575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterizing the induction of diabetes in juvenile cynomolgus monkeys with different doses of streptozotocin.
    Zou C; Wang J; Wang S; Huang F; Ren Z; Chen Z; Zhang Y
    Sci China Life Sci; 2012 Mar; 55(3):210-8. PubMed ID: 22527517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exendin-4 potentiates insulinotropic action partly via increasing beta-cell proliferation and neogenesis and decreasing apoptosis in association with the attenuation of endoplasmic reticulum stress in islets of diabetic rats.
    Kwon DY; Kim YS; Ahn IS; Kim DS; Kang S; Hong SM; Park S
    J Pharmacol Sci; 2009 Dec; 111(4):361-71. PubMed ID: 20019445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells.
    Herold KC; Bloch TN; Vezys V; Sun Q
    Diabetes; 1995 Mar; 44(3):354-9. PubMed ID: 7883124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdifferentiation of both intra- and extra-islet cells into beta cells in nicotinamide treated neonatal diabetic rats: An in situ hybridization and double immunohistochemical study.
    Kaya-Dagistanli F; Ozturk M
    Acta Histochem; 2020 Oct; 122(7):151612. PubMed ID: 33066834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Streptozotocin causes pancreatic beta cell failure via early and sustained biochemical and cellular alterations.
    Adeghate E; Hameed RS; Ponery AS; Tariq S; Sheen RS; Shaffiullah M; Donáth T
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):699-707. PubMed ID: 20496316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of alpha-cell function by the beta-cell during hypoglycemia in Wistar rats: the "switch-off" hypothesis.
    Zhou H; Tran PO; Yang S; Zhang T; LeRoy E; Oseid E; Robertson RP
    Diabetes; 2004 Jun; 53(6):1482-7. PubMed ID: 15161752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B; Serradas P
    Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of alpha-cell function by the beta-cell in isolated human and rat islets deprived of glucose: the "switch-off" hypothesis.
    Hope KM; Tran PO; Zhou H; Oseid E; Leroy E; Robertson RP
    Diabetes; 2004 Jun; 53(6):1488-95. PubMed ID: 15161753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological changes in the rat endocrine pancreas within 12 h of intravenous streptozotocin administration.
    Nagasao J; Yoshioka K; Amasaki H; Tsujio M; Ogawa M; Taniguchi K; Mutoh K
    Anat Histol Embryol; 2005 Feb; 34(1):42-7. PubMed ID: 15649226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats.
    Wang T; Zhang P; Zhang X; Cao T; Zheng C; Yu B
    Surg Obes Relat Dis; 2017 Feb; 13(2):250-260. PubMed ID: 27865809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
    Reddy S; Young M; Poole CA; Ross JM
    Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new animal model of non-insulin-dependent diabetes mellitus with hypertension: neonatal streptozotocin treatment in spontaneously hypertensive rats.
    Iwase M
    Fukuoka Igaku Zasshi; 1991 Jul; 82(7):415-27. PubMed ID: 1833297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Destruction of pancreatic beta cells in rats by complete Freund's adjuvant combined with non-diabetogenic doses of streptozotocin.
    Kohnert KD; Odselius R; Fält K; Ziegler B; Ziegler M; Falkmer S
    Diabetes Res; 1987 May; 5(1):1-11. PubMed ID: 2957141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.